Lipella Pharmaceuticals LIPO
LIPO
$0.00 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lipella Pharmaceuticals Inc. (LIPO) EBIT (2022 - 2025)

Updated

Lipella Pharmaceuticals (LIPO) posted EBIT of -$1.27 million for Q3 2025, compared with -$1.46 million a year earlier.

Analysis

Lipella Pharmaceuticals Inc. (LIPO) EBIT (2022 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, EBIT at Lipella Pharmaceuticals was -$5.41 million; for FY2024, it came in at -$5.08 million.

  • In prior years, Lipella Pharmaceuticals' EBIT was -$4.75 million in FY2023, -$2.59 million in FY2022 and -$1.92 million in FY2021.
  • The Q3 2025 figure stands as the highest quarterly EBIT since Q2 2024.
  • According to Business Quant data, EBIT for the three prior quarters was -$1.36 million (Q2 2025), -$1.33 million (Q1 2025) and -$1.45 million (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.27 Mn
Jun 30, 2025 -1.36 Mn
Mar 31, 2025 -1.33 Mn
Dec 31, 2024 -1.45 Mn
Sep 30, 2024 -1.46 Mn
Jun 30, 2024 -952,189.00
Mar 31, 2024 -1.22 Mn
Dec 31, 2023 -729,594.00
Sep 30, 2023 -1.36 Mn
Jun 30, 2023 -1.58 Mn
Mar 31, 2023 -1.08 Mn
Dec 31, 2022 -359,263.00
Sep 30, 2022 -712,642.00
Jun 30, 2022 -781,147.00
Mar 31, 2022 -736,663.00
API Access

Lipella Pharmaceuticals Inc. EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=LIPO&period=max&api_key=YOUR_API_KEY